The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDI.L Regulatory News (RDI)

  • There is currently no data for RDI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - RDI Reit Plc

1 Apr 2019 08:22

RNS Number : 6366U
Sanlam Investment Mgmt (Pty) Ltd
01 April 2019
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Sanlam Investment Management (Pty) Ltd, Sanlam Private Investments (UK) Ltd

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Not applicable

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

RDI Reit Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

Not applicable

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

29 March 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

1,263,078.00

 

0.33

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

 

1,263,078.00

 

0.33

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

Ordinary

 

Purchase

 

7 841

 

R28.50

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

01/04/2019

Contact name:

Mlamli Roji

Telephone number*:

27219502083

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETEAXLFEAENEEF
Date   Source Headline
24th Nov 20207:00 amRNSFinalisation Announcement for Cash Dividend
23rd Nov 20207:00 amRNSChange of Registered Office Address
9th Nov 20209:00 amRNSHolding(s) in Company
5th Nov 20207:10 amRNSCEO retirement and succession
5th Nov 20207:05 amRNSDividend Declaration
5th Nov 20207:00 amRNSResults for the year ended 31 August 2020
2nd Nov 20207:00 amRNSRDI completes on disposal of UK retail parks
16th Oct 20207:00 amRNSRent Collection Update
14th Sep 20207:00 amRNSNotice of Results
7th Sep 20207:00 amRNSDisposal of UK retail parks portfolio for £156.9m
2nd Sep 20207:00 amRNSDisposal of Schloss-Strassen Center, Berlin
24th Aug 20209:00 amRNSHolding(s) in Company
18th Aug 20209:00 amRNSTR1 Correction Announcement
3rd Aug 20204:35 pmRNSPrice Monitoring Extension
23rd Jul 20207:00 amRNSLink 9 Bicester fully let to Arrival
22nd Jul 20204:00 pmRNSChanges to the Board
13th Jul 20203:05 pmRNSChanges to the Board
13th Jul 20203:00 pmRNSHolding(s) in Company
7th Jul 20207:00 amRNSTrading Update
1st Jul 20204:10 pmRNSHolding(s) in Company
29th Jun 20203:50 pmRNSStarwood Capital to acquire shareholding in RDI
28th May 202010:00 amRNSHolding(s) in Company
11th May 20207:00 amRNSInterim Results for the 6 m/e 29 February 2020
29th Apr 20203:00 pmRNSCompliance with LR 9.2.6E R (1)
28th Apr 20207:00 amRNSNotice of Results for the 6 m/e 29 February 2020
6th Apr 20207:00 amRNSCOVID-19 Update
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20207:02 amRNSHolding(s) in Company
19th Mar 20207:00 amRNS£34.4m Strategic Disposals and COVID-19 Update
2nd Mar 20202:45 pmRNSHolding(s) in Company
13th Feb 20203:15 pmRNSHolding(s) in Company
23rd Jan 20203:30 pmRNSAGM Voting Results and Changes to the Board
13th Jan 20207:00 amRNSUpdate on lettings progress & strategic disposals
17th Dec 20197:00 amRNSPosting of AR, Notice of AGM and Changes to Board
2nd Dec 201910:00 amRNSPDMR Share Dealing
2nd Dec 201910:00 amRNSGrant of Contingent Awards Under Share Plans
29th Nov 20199:30 amRNSVesting of Share Awards, Admission of New Shares
18th Nov 20193:30 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSFinalisation Announcement of Cash Dividend
24th Oct 20197:05 amRNSDeclaration of a Cash Dividend
24th Oct 20197:00 amRNSResults for the Year Ended 31 August 2019
9th Oct 20194:00 pmRNSChanges to the Board
18th Sep 20197:00 amRNSRDI sells Bahnhof Altona Center, Hamburg
4th Sep 20197:00 amRNSNotice of Results for the Y/E 31 August 2019
3rd Sep 20197:00 amRNSInvestor Day Presentation and Property Tour
20th Aug 20197:00 amRNSRDI concludes £75m refinancing of LSO portfolio
13th Aug 201912:00 pmRNSHolding(s) in Company
29th Jul 20197:00 amRNSRDI secures significant leasing transactions
24th Jul 201910:00 amRNSPDMR Share Dealing
5th Jun 20197:00 amRNSRefinancing of London Serviced Office Portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.